Bangalore 09th November, 2023: IOL Chemicals and Pharmaceuticals Ltd, a leading manufacturer of pharmaceutical APIs and speciality chemicals, announced its financial results for the second quarter and first half year ended September 30, 2023.
Q2 & H1 FY24 Financial Highlights
(Rs in Crore)
| Particulars | Q2 FY24 | Q1 FY24 | % QoQ | Q2 FY23 | % YoY | H1 FY24 | H1 FY23 | % YoY |
| Total Income | 552.41 | 570.24 | -3.1% | 546.47 | 1.1% | 1,122.65 | 1,116.65 | |
| EBITDA | 71.21 | 79.92 | -10.9% | 36.73 | 93.9% | 151.13 | 97.92 | |
| EBITDA Margin (%) | 12.9% | 14.0% | 6.7% | 13.5% | 8.8% | |||
| PAT | 37.79 | 46.21 | -18.2% | 15.67 | 141.2% | 84.00 | 50.58 | |
| PAT Margin (%) | 6.8% | 8.1% | 2.9% | 7.5% | 4.5% |
Commenting on the performance, Mr. Vikas Gupta, Joint Managing Director said, “With the global economy showing signs of stability, the pharmaceutical and chemical trade are likely to revive in the second half of this fiscal. We, at IOL, are pleased to announce another stellar quarterly performance amid the backdrop of strong growth in pharmaceutical sector. As the Company positions itself for upcoming opportunities through entry into regulated markets and focus on improved efficiencies, we are hopeful of sustained performance, thereby driving value creation for the shareholders and investors, alike.”